DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,110	1,658	4,350	3,125	4,002	3,410
Short-Term Investments	3,600	5,100	7,620	3,240	11,340	5,970
Trading Asset Securities	2,070	1,104	1,489	1,597	3,080	2,979
Cash & Short-Term Investments	6,780	7,863	13,458	7,962	18,422	12,360
Cash Growth	-37.57%	-41.58%	69.03%	-56.78%	49.05%	3.85%
Accounts Receivable	20,033	20,383	22,755	18,137	16,719	16,317
Other Receivables	1,367	1,006	1,422	1,313	1,517	1,696
Receivables	21,400	21,389	24,176	19,450	18,236	18,013
Inventory	30,197	31,340	26,678	23,413	18,682	19,713
Prepaid Expenses	670.05	480.34	310.27	294.59	287.91	178.3
Other Current Assets	191.33	534.76	597.23	92.92	511.03	661.91
Total Current Assets	59,238	61,607	65,220	51,213	56,139	50,926
Property, Plant & Equipment	85,888	91,702	94,351	89,857	68,245	68,778
Long-Term Investments	3,823	3,798	10,929	10,475	8,639	13,819
Goodwill	693.16	693.16	693.16	693.16	693.16	2,124
Other Intangible Assets	28,997	28,630	27,822	26,972	23,775	19,762
Long-Term Deferred Tax Assets	3,329	3,622	3,992	3,642	4,172	3,734
Other Long-Term Assets	20,003	15,831	16,154	16,204	15,713	15,904
Total Assets	201,972	205,884	219,163	199,056	177,376	175,047
Accounts Payable	13,276	11,597	15,783	12,925	8,026	8,048
Accrued Expenses	2,514	2,559	2,669	2,958	1,504	1,129
Short-Term Debt	64,136	59,199	74,457	59,055	56,347	56,957
Current Portion of Long-Term Debt	32,771	34,238	28,189	3,250	2,500	750.63
Current Portion of Leases	128.68	117.78	149.65	201.76	238.02	307.79
Current Income Taxes Payable	136.45	46.26	27.35	380.05	1,463	560.87
Current Unearned Revenue	42.35	42.35	42.35	50.19	69.05	67.22
Other Current Liabilities	8,381	9,893	6,631	4,440	5,189	9,787
Total Current Liabilities	121,386	117,693	127,948	83,260	75,335	77,608
Long-Term Debt	999.91	5,566	7,500	27,307	10,796	5,249
Long-Term Leases	181.24	151.94	229.92	251.93	269.24	291.61
Other Long-Term Liabilities	2,790	2,334	2,457	3,271	3,157	3,091
Total Liabilities	128,731	129,515	141,809	117,365	93,960	88,894
Common Stock	9,308	9,308	9,308	9,308	9,308	9,285
Additional Paid-In Capital	33,023	33,023	33,023	33,023	33,023	32,078
Retained Earnings	36,535	39,383	41,562	45,862	46,529	46,807
Treasury Stock	-9,162	-9,162	-9,162	-9,162	-9,162	-9,162
Comprehensive Income & Other	-1,115	-554.04	-1,500	-1,040	-24.6	2,971
Total Common Equity	68,590	71,999	73,232	77,993	79,674	81,979
Minority Interest	4,651	4,371	4,121	3,699	3,742	4,173
Shareholders' Equity	73,241	76,370	77,353	81,691	83,416	86,152
Total Liabilities & Equity	201,972	205,884	219,163	199,056	177,376	175,047
Total Debt	98,217	99,274	110,525	90,066	70,150	63,556
Net Cash (Debt)	-91,438	-91,411	-97,067	-82,104	-51,728	-51,197
Net Cash Per Share	-5255.75	-5218.53	-5501.68	-4709.91	-2962.69	-2957.90
Filing Date Shares Outstanding	17.49	17.52	17.52	17.52	17.52	17.47
Total Common Shares Outstanding	17.49	17.52	17.52	17.52	17.52	17.47
Working Capital	-62,148	-56,085	-62,728	-32,047	-19,196	-26,681
Book Value Per Share	3920.89	4110.33	4180.70	4452.48	4548.48	4692.74
Tangible Book Value	38,900	42,676	44,717	50,327	55,206	60,093
Tangible Book Value Per Share	2223.66	2436.30	2552.81	2873.10	3151.65	3439.93
Land	-	18,964	19,097	19,097	19,097	19,097
Buildings	-	67,440	67,144	45,065	45,065	45,065
Machinery	-	62,371	56,983	42,936	44,633	44,017
Construction In Progress	-	470.04	2,765	29,549	3,035	594.6

Updated May 14, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.